Free Trial

LENSAR (LNSR) Competitors

LENSAR logo
$12.64 -0.32 (-2.47%)
As of 02:55 PM Eastern

LNSR vs. BFLY, RXST, AVNS, EMBC, DCTH, BVS, KIDS, AXGN, NPCE, and SMLR

Should you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), Embecta (EMBC), Delcath Systems (DCTH), Bioventus (BVS), OrthoPediatrics (KIDS), AxoGen (AXGN), NeuroPace (NPCE), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

LENSAR vs. Its Competitors

LENSAR (NASDAQ:LNSR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability, institutional ownership and community ranking.

LENSAR currently has a consensus target price of $15.00, suggesting a potential upside of 18.67%. Butterfly Network has a consensus target price of $4.00, suggesting a potential upside of 64.61%. Given Butterfly Network's stronger consensus rating and higher probable upside, analysts clearly believe Butterfly Network is more favorable than LENSAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Butterfly Network
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Butterfly Network received 2 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 72.73% of users gave Butterfly Network an outperform vote while only 37.50% of users gave LENSAR an outperform vote.

CompanyUnderperformOutperform
LENSAROutperform Votes
6
37.50%
Underperform Votes
10
62.50%
Butterfly NetworkOutperform Votes
8
72.73%
Underperform Votes
3
27.27%

40.2% of LENSAR shares are held by institutional investors. Comparatively, 37.8% of Butterfly Network shares are held by institutional investors. 38.5% of LENSAR shares are held by insiders. Comparatively, 25.2% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

LENSAR has a net margin of -34.03% compared to Butterfly Network's net margin of -129.25%. Butterfly Network's return on equity of -42.68% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR-34.03% -49.02% -21.12%
Butterfly Network -129.25%-42.68%-30.31%

LENSAR has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.54, indicating that its share price is 154% more volatile than the S&P 500.

In the previous week, LENSAR and LENSAR both had 4 articles in the media. LENSAR's average media sentiment score of 0.82 beat Butterfly Network's score of 0.17 indicating that LENSAR is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LENSAR
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Butterfly Network
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

LENSAR has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$57.07M2.61-$14.38M-$4.85-2.61
Butterfly Network$85.63M7.02-$133.70M-$0.29-8.38

Summary

Butterfly Network beats LENSAR on 11 of the 17 factors compared between the two stocks.

Get LENSAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LNSR vs. The Competition

MetricLENSARSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$149.05M$4.37B$5.60B$8.62B
Dividend YieldN/A42.67%5.28%4.18%
P/E Ratio-8.6629.0827.2520.00
Price / Sales2.6171.08413.35158.30
Price / CashN/A51.0838.2534.64
Price / Book4.265.827.124.70
Net Income-$14.38M$67.63M$3.24B$248.14M
7 Day Performance-3.22%0.37%2.71%2.48%
1 Month Performance-9.39%15.27%8.93%6.15%
1 Year Performance159.02%18.37%31.30%13.59%

LENSAR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LNSR
LENSAR
1.2783 of 5 stars
$12.64
-2.5%
$15.00
+18.7%
+168.3%$149.05M$57.07M-8.66110
BFLY
Butterfly Network
2.2785 of 5 stars
$2.48
flat
$4.00
+61.3%
+169.6%$613.28M$85.63M-5.39460Positive News
Gap Up
RXST
RxSight
3.2784 of 5 stars
$15.30
+1.7%
$37.90
+147.7%
-74.1%$611.18M$148.31M-18.43220Positive News
Gap Up
AVNS
Avanos Medical
1.7569 of 5 stars
$12.63
+1.4%
N/A-37.4%$584.06M$689.20M37.154,040Positive News
EMBC
Embecta
4.2801 of 5 stars
$9.91
+1.2%
$19.33
+95.1%
-18.6%$579.17M$1.08B9.911,900
DCTH
Delcath Systems
3.6278 of 5 stars
$15.95
-2.6%
$24.00
+50.5%
+132.0%$555.48M$53.85M-11.8160
BVS
Bioventus
2.5559 of 5 stars
$6.72
+0.4%
$14.33
+113.3%
+2.8%$552.01M$567.70M-11.021,200Positive News
KIDS
OrthoPediatrics
4.3426 of 5 stars
$21.54
+1.7%
$35.83
+66.4%
-25.8%$523.14M$212.45M-17.51200
AXGN
AxoGen
2.3643 of 5 stars
$10.41
-4.7%
$22.20
+113.3%
+37.8%$474.11M$194.52M-32.53450High Trading Volume
NPCE
NeuroPace
3.755 of 5 stars
$12.93
-1.7%
$15.50
+19.9%
+85.4%$431.31M$84.31M-12.93170Trending News
Analyst Revision
SMLR
Semler Scientific
2.9158 of 5 stars
$33.99
+3.1%
$71.00
+108.9%
-20.1%$379.06M$49.23M6.92120Options Volume
High Trading Volume

Related Companies and Tools


This page (NASDAQ:LNSR) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners